Abstract: A decoupling circuit for enhancing isolation of two antennas is disclosed. The two antennas are substantially symmetrically disposed on a substrate. The decoupling circuit includes a first and second metal strips parallel disposed between the two antennas and electrically connected to a ground, a connection strip electrically connected between terminals of the first and second metal strips, to substantially form a doorframe structure, a first comb structure comprising a plurality of metal segments parallel to each other, disposed on the substrate, electrically connected to and perpendicular to the first metal strip, and a second comb structure comprising a plurality of metal segments parallel to each other, disposed on the substrate, electrically connected to and perpendicular to the second metal strip.

Abstract: An isolation feature with a nitrogen-doped fill dielectric and a method of forming the isolation feature are disclosed. In an exemplary embodiment, the method of forming the isolation feature comprises receiving a substrate having a top surface. A recess is etched in the substrate, the recess extending from the top surface into the substrate. A dielectric is deposited within the recess such that the depositing of the dielectric includes introducing nitrogen during a chemical vapor deposition process. Accordingly, the deposited dielectric includes a nitrogen-doped dielectric. The deposited dielectric may include a nitrogen-doped silicon oxide. In some embodiments, the depositing of the dielectric disposes the nitrogen-doped dielectric in contact with a surface of the recess. In further embodiments, a liner material is deposited within the recess prior to the depositing of the dielectric within the recess.

Abstract: A decoupling circuit for enhancing isolation of two antennas is disclosed. The two antennas are substantially symmetrically disposed on a substrate. The decoupling circuit includes a first and second metal strips parallel disposed between the two antennas and electrically connected to a ground, a connection strip electrically connected between terminals of the first and second metal strips, to substantially form a doorframe structure, a first comb structure comprising a plurality of metal segments parallel to each other, disposed on the substrate, electrically connected to and perpendicular to the first metal strip, and a second comb structure comprising a plurality of metal segments parallel to each other, disposed on the substrate, electrically connected to and perpendicular to the second metal strip.

Abstract: A decoupling circuit for enhancing isolation of two monopole antennas is disclosed. The two monopole antennas substantially symmetrically stand on a bottom, and a gap is formed between the two monopole antennas. The decoupling circuit includes a grounding element located on the bottom and electrically connected to a ground, a connection bar substantially perpendicular to the bottom, including a first terminal electrically connected to the grounding element, a second terminal extending to the gap, a first branch extending from the second terminal of the connection bar to a first monopole antenna of the two monopole antennas, and a second branch extending from the second terminal of the connection bar to a second monopole antenna of the two monopole antennas.

Abstract: Disclosed is a microcapsule composition for inhibiting an ethylene response in plants, which comprises a plurality of microcapsules, each including an agent for blocking an ethylene binding site in plants in an oil droplet, and a coating encapsulating the oil droplet and the agent for blocking the ethylene binding site in plants. A method for preparing microcapsules of an agent for blocking the ethylene binding site in plants, and a method for inhibiting an ethylene response in plants are also disclosed.

Abstract: An isolated Lactobacillus paracasei strain LT12 and its genetically-engineered variant that possesses immune regulating activity and uses thereof for regulating immune responses and treating allergy.

Abstract: An isolated Lactobacillus paracasei strain LT12 and its genetically-engineered variant that possesses immune regulating activity and uses thereof for regulating immune responses and treating allergy.

Abstract: Disclosed is a microcapsule composition for inhibiting an ethylene response in plants, which comprises a plurality of microcapsules, each including an agent for blocking an ethylene binding site in plants in an oil droplet, and a coating encapsulating the oil droplet and the agent for blocking the ethylene binding site in plants. A method for preparing microcapsules of an agent for blocking the ethylene binding site in plants, and a method for inhibiting an ethylene response in plants are also disclosed.

Abstract: The present invention relates to a pharmaceutical composition for rapidly reducing the uric acid level in blood in a subject, which comprises anserine in an amount of greater than 50 mg to about 600 mg. The present invention further relates to a package comprising the pharmaceutical composition comprising anserine, and a label and/or an insert indicating that the composition is administered to a subject to provide anserine in an amount of greater than 50 mg to about 600 mg per dose. In addition, the present invention relates to a method for rapidly reducing the uric acid level in blood in a subject, which comprises administering anserine in an amount of greater than 50 mg to about 600 mg to the subject.

Abstract: The present invention relates to a pharmaceutical composition for rapidly reducing the uric acid level in blood in a subject, which comprises anserine in an amount of greater than 50 mg to about 600 mg. The present invention further relates to a package comprising the pharmaceutical composition comprising anserine, and a label and/or an insert indicating that the composition is administered to a subject to provide anserine in an amount of greater than 50 mg to about 600 mg per dose. In addition, the present invention relates to a method for rapidly reducing the uric acid level in blood in a subject, which comprises administering anserine in an amount of greater than 50 mg to about 600 mg to the subject.